title: The Year in Cardiology 2012: focus on cardiovascular disease prevention.
abstract: Current data suggest that advances in cardiovascular (CV) treatment have resulted in significant reduction in CV mortality but also in prolongation of life with disability. Focus on CV prevention is likely to reverse this unfavourable trend. In this review we provide information on the new European guidelines on CV prevention and discuss biomarkers and vascular imaging techniques which can assist in refining CV risk prediction. Finally, we provide new information on lifestyle and pharmacological advances which are likely to result in significant CV risk reduction.
authors.affiliation: National Centre for Cardiovascular Prevention and Outcomes, Institute of Cardiovascular Science, University College London, UK.
authors.forename: Marietta
authors.initials: M
authors.lastname: Charakida
authors.forename: Stefano
authors.initials: S
authors.lastname: Masi
authors.forename: John Eric
authors.initials: JE
authors.lastname: Deanfield
mesh_terms: D015415:Biomarkers / Q000097:blood; D002253:Carbonated Beverages / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000172:deficiency; D002986:Clinical Trials as Topic; D003952:Diagnostic Imaging / Q000379:methods / Q000639:trends; D042241:Early Diagnosis; D005544:Forecasting; D006801:Humans; D009765:Obesity / Q000150:complications; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D008076:Cholesterol, HDL